Symbols / APTO
APTO Chart
About
No company description available for this symbol.
Fundamentals
Scroll to Statements| Sector | — | Industry | — | Market Cap | — |
| Enterprise Value | — | Income | — | Sales | — |
| Book/sh | — | Cash/sh | — | Dividend Yield | — |
| Payout | — | Employees | — | IPO | — |
| P/E | — | Forward P/E | — | PEG | — |
| P/S | — | P/B | — | P/C | — |
| EV/EBITDA | — | EV/Sales | — | Quick Ratio | — |
| Current Ratio | — | Debt/Eq | — | LT Debt/Eq | — |
| EPS (ttm) | — | EPS next Y | — | EPS Growth | — |
| Revenue Growth | — | Earnings | 2025-03-28 08:00 | ROA | — |
| ROE | — | ROIC | — | Gross Margin | — |
| Oper. Margin | — | Profit Margin | — | Shs Outstand | — |
| Shs Float | — | Short Float | — | Short Ratio | — |
| Short Interest | — | 52W High | — | 52W Low | — |
| Beta | — | Avg Volume | — | Volume | — |
| Target Price | — | Recom | — | Prev Close | $0.00 |
| Price | $1.71 | Change | — |
Valuation Models
Price estimates from analyst targets and simple models.
1. Analyst consensus
—
Mean price target
2. Current target
—
Latest analyst target
3. DCF / Fair value
—
Simplified FCF or EPS-based estimate
Ratings
Latest analyst rating changes
| Date | Action | Analyst | Rating Change | Price Target |
|---|---|---|---|---|
| 2025-03-28 | main | HC Wainwright & Co. | Buy → Buy | $6 |
| 2025-02-12 | reit | HC Wainwright & Co. | Buy → Buy | $2 |
| 2025-01-10 | reit | HC Wainwright & Co. | Buy → Buy | $2 |
| 2024-12-10 | reit | HC Wainwright & Co. | Buy → Buy | $2 |
| 2024-12-03 | reit | HC Wainwright & Co. | Buy → Buy | $2 |
| 2024-11-20 | main | HC Wainwright & Co. | Buy → Buy | $2 |
- Aptose Biosciences shares to delist from Nasdaq as of April 2 - Yahoo Finance Wed, 02 Apr 2025 07
- Aptose Biosciences Receives Extension from Nasdaq to Demonstrate Compliance with Listing Requirements - Quiver Quantitative hu, 19 Dec 2024 08
- Aptose Biosciences Inc. Announces Reverse Share Split to Enhance Compliance with Nasdaq Listing Requirements - Nasdaq ue, 18 Feb 2025 08
- Aptose shares tumble following Nasdaq delisting decision - Investing.com ue, 01 Apr 2025 07
- Aptose Common Shares to Delist from Nasdaq as of April 2, 2025 - Yahoo Finance ue, 01 Apr 2025 07
- APTO - Aptose Bioscienc Latest Stock News & Market Updates - Stock Titan Sat, 12 Sep 2020 10
- Why Aptose Biosciences Stock Is Skyrocketing Today - The Motley Fool Wed, 24 Mar 2021 07
- 3 Stocks With 1,000% Upside Potential - InvestorPlace Sun, 21 May 2023 07
- Aptose Biosciences Enters $25 Million Common Share Purchase Agreement to Support AML Therapy Development - Nasdaq hu, 13 Feb 2025 08
- Aptos price today, APT to USD live price, marketcap and chart - CoinMarketCap ue, 13 Sep 2022 03
- Data Center IT Asset Disposition (ITAD) Business Report 2025: Market to Hit $19.1 Billion by 2030 with Apto Solutions, Arrow Electronics, Atlantix Global Systems, CloudBlue, DataServ at the Forefront - Yahoo Finance Wed, 05 Nov 2025 08
- Buildout acquires Apto, bolsters CRE marketing for brokers - HousingWire Wed, 19 Jan 2022 08
- Aptose Biosciences plans reverse stock split to meet Nasdaq rules - Investing.com UK ue, 18 Feb 2025 08
- Aptose Biosciences price target raised to $6 from $2 at H.C. Wainwright - Yahoo Finance Sat, 29 Mar 2025 07
- Aptose Biosciences shareholders approve reverse stock split - Investing.com UK Wed, 29 Jan 2025 08
Insider Transactions
No recent insider transactions.
Financials
No financial statements available. Data is sourced from Yahoo Finance and cached; historical storage may be added later.
SEC Filings
No SEC filings found for this symbol (may be non-US or ticker not in SEC index).
Public Trades for APTO
| Date | User | Asset | Broker | Type | Position Size | Entry Price | Patterns |
|---|